DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Adverse drug reactions:   

Frequency Defined  

>10%  

Dry mouth  

1-10%  

Rash  

Dyspepsia  

Abdominal pain  

Constipation  

Tachycardia   

Constipation  

Dry eyes  

Dyspepsia  

Flatulence  

Urinary retention  

Urinary tract infection  

Nasopharyngitis  

Nasal dryness  

Post-marketing Reports  

Gastritis  

Palpitations  

supraventricular tachycardia  

chest pain  

syncope  

hypertensive crisis  

Stevens-Johnson syndrome  

anaphylactic reaction  

angioedema  

Dizziness  

hallucinations  

somnolence  

delirium  

Pregnancy warnings:     

Pregnancy Category: C 

Breastfeeding warnings:  

The release of the drug into the human breastmilk is unknown 

Pregnancy Categories:      

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.      

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      

Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits      

Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.      

Category N: There is no data available for the drug under this category

Patient Information Leaflet  

Generic Name: trospium 

Pronunciation: tros-PEE-um 

Why do we use trospium? 

trospium is an anticholinergics agent which acts as a Urinary antispasmodic. It is used to treat overactive bladder, symptoms of urinary urgency, incontinence, and frequency.